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Background
Coadministration of various drugs together with antide-
pressants can induce different side-effects in depressed
patients. The authors report the case of a middle-aged
woman, suffering from recurrent unipolar mood disorder,
who developed an acute cutaneous reaction after the con-
comitant use of venlafaxine 225 mg/day and a combina-
tion product of orphenadrine citrate 105 mg/day and
paracetamol 1350 mg/day.
Materials and Methods
To address whether the occurrence of this cutaneous reac-
tion was the result of a possible allergic reaction or a drug-
drug interaction.
In an attempt to identify the origin of this adverse effect,
skin prick tests were performed in the patient with
orphenadrine citrate and paracetamol in multiple dilu-
tions. Five non-depressed patients, without a medical his-
tory of atopy, to whom it was recently prescribed
orphenadrine citrate and paracetamol, were evaluated
and were used as controls.
Results
Skin tests to orphenadrine citrate and paracetamol were
negative both for the patient under consideration, as well
as for the members of the control group. In addition,
none of the individuals studied developed any delayed
skin test reactions.
Discussion
According to our findings, the possibility of an allergic
reaction due to the concomitant use of venlafaxine and
this combination product of orphenadrine citrate and
paracetamol cannot be supported, since skin prick tests
were negative. Thus, it is suggested that this cutaneous
reaction is probably due to a drug-drug interaction
between venlafaxine and this combination product.
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